Our projects
40
Projects
-
The TI Pharma Portfolio: FES Projects
Collaborative pharmaceutical research addressing WHO Priority Medicines agenda -
The CTMM Portfolio
Public-private partnerships to develop innovative medical technologies -
ADAPT SMART
Accelerating early access to innovative medicines for appropriate patient groups -
Phosphodiesterase Inhibitors for Neglected Parasitic Diseases PDE4NPD
Lead identification and optimization, to develop novel drugs for neglected diseases